Markets

Market

News Details

(12/02/2026 12:50)

Kwality Pharma. Q3 net profit jumps 87.47% at Rs 16.01 cr

The company reported standalone net profit of Rs 16.01 crore for the quarter ended December 31, 2025 as compared to Rs 8.54 crore in the same period last year, registering a year-on-year growth of 87.47 per cent.

Net revenue of the company rose substantially by 46.24 per cent at Rs 123.44 crore in October-December quarter of this fiscal as against Rs 84.41 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 39.75 per cent to Rs 93.49 crore from Rs 66.90 crore in year ago period.

Other Income dipped by 18.46 per cent at Rs 0.53 crore versus (Dec'24 Rs 0.65 crore).

Operating Profit surged by 71.05 per cent to Rs 29.95 crore as against Rs 17.51 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 16.97 per cent in December quarter.

Interest grew by 12.73 per cent y-o-y to Rs 2.48 crore, while Taxation increased by 121.25 per cent at Rs 6.35 crore (Dec'24 Rs 2.87 crore).

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.